| $75M2025-03-17 |  Maxion Therapeutics | Elena Viboch |
| $75M2025-03 | Maxion Therapeutics | Elena Viboch |
| $350M2025-02-26 |  Eikon Therapeutics | Elena Viboch |
| $350M2025-02 | Eikon Therapeutics | Elena Viboch |
| $25M2025-01-27 |  Manas AI | Hemant Taneja, Elena Viboch |
| $25M2025-01 | Manas AI | Reid Hoffman, Hemant Taneja, Elena Viboch |
| $16M2024-11-13 |  MedeLoop | Elena Viboch, Magaly Charbonneau |
| $16M2024-11 | Medeloop | Elena Viboch |
| $180M2024-10-23 |  Alpha-9 Oncology | Elena Viboch |
| $180M2024-10 | Alpha-9 Oncology | Elena Viboch |
| $110M2024-08-22 |  Elektrofi | Elena Viboch |
| $110M2024-08 | Elektrofi | Elena Viboch |
| $150M2024-03-01 |  Parabilis Medicines | Elena Viboch |
| $150M2024-03 | Parabilis Medicines | Elena Viboch |
| $101M2023-12-05 |  Odyssey Therapeutics | Elena Viboch, AB Magnitude Ventures Group |
| $100M2023-12 | Odyssey Therapeutics | Elena Viboch |
| $8M2023-09-20 | MedeLoop | Elena Viboch |
| $8M2023-09 | Medeloop | Elena Viboch |
| $75M2023-08-09 |  Georgiamune | Deep Nishar, Elena Viboch |
| $75M2023-08 | Georgiamune | Deep Nishar, Elena Viboch |
| $10M2023-04-10 |  Ctrl Therapeutics | General Catalyst, Intermountain Health, Elena Viboch |
| $10M2023-04 | CTRL Therapeutics | Elena Viboch |
| $20M2023-02-08 |  Faro AI | General Catalyst, Elena Viboch, S32, Northpond Ventures, Polaris Partners, Zetta Venture Partners |
| $20M2023-02 | Faro Health | Elena Viboch |
| $200M2023-01-25 |  Paradigm | Hemant Taneja, Elena Viboch, Bilal Zuberi |
| $200M2023-01 | Paradigm | Robert Nelsen, Jay Markowitz, Hemant Taneja, Elena Viboch |
| $160M2022-12-29 | ArriVent | Elena Viboch |
| $12M2022-12-08 |  Tahoe Therapeutics | Gaurav Garg, Deep Nishar, Elena Viboch |
| $160M2022-12 | ArriVent | Elena Viboch |
| $12M2022-12 | Tahoe Therapeutics | Deep Nishar, Elena Viboch |
| $34M2022-11-30 |  Vial | Hemant Taneja, Elena Viboch |
| $67M2022-11-30 | Vial | General Catalyst, BoxGroup, Jeffrey Silverstein, Nimi Katragadda, Adam Rothenberg, David Tisch, Hemant Taneja, Elena Viboch |
| $67M2022-11 | Vial | Hemant Taneja, Elena Viboch |
| $34M2022-11 | Vial | Hemant Taneja, Elena Viboch |
| $170M2022-10-13 | Odyssey Therapeutics | Elena Viboch |
| $170M2022-10 | Odyssey Therapeutics | Elena Viboch |
| $7M2022-08-24 | TenSixty BioSciences | Elena Viboch |
| $7M2022-08 | TenSixty BioSciences | Elena Viboch |
| $150M2022-02-03 |  Dewpoint Therapeutics | ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset, General Catalyst, BECO Capital, 3E Bioventures Capital, Elena Viboch |
| $150M2022-02 | Dewpoint Therapeutics | Kristina Burow, Elena Viboch |
| $190M2022-01-10 |  Maze Therapeutics | Elena Viboch |
| $520M2022-01-06 | Eikon Therapeutics | Elena Viboch |
| $520M2022-01 | Eikon Therapeutics | Elena Viboch |
| $190M2022-01 | Maze Therapeutics | Jonathan Lim, Elena Viboch |
| $180M2021-07-28 |  Deep Genomics | Deep Nishar, Elena Viboch |
| $180M2021-07 | Deep Genomics | Vinod Khosla, Deep Nishar, Elena Viboch |
| $80M2020-12-08 | Pear Therapeutics | Elena Viboch |
| $80M2020-12 | Pear Therapeutics | Elena Viboch |
